Literature DB >> 5935358

Synthesis of clotting factors by the isolated perfused rat liver.

J P Olson, L L Miller, S B Troup.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5935358      PMCID： PMC292746          DOI： 10.1172/JCI105384

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  19 in total

1.  PROTHROMBIN SYNTHESIS IN THE DOG.

Authors:  G F ANDERSON; M I BARNHART
Journal:  Am J Physiol       Date:  1964-05

2.  Studies on the nature of the circulating anticoagulant directed against antihemophilic factor: with notes on an assay for anthemophilic factor.

Authors:  R T BRECKENRIDGE; C D RATNOFF
Journal:  Blood       Date:  1962-08       Impact factor: 22.113

3.  The specific assay of Prower-Stuart factor and factor VII.

Authors:  K W DENSON
Journal:  Acta Haematol       Date:  1961-02       Impact factor: 2.195

4.  Deficient synthesis of factor VII by liver tissue of fetal and newborn rats.

Authors:  G M GRODSKY; M KROPATKIN; J G POOL
Journal:  Am J Physiol       Date:  1960-07

5.  Plasma clotting factors in chronic hepatocellular disease.

Authors:  S I RAPAPORT; S B AMES; S MIKKELSEN; J R GOODMAN
Journal:  N Engl J Med       Date:  1960-08-11       Impact factor: 91.245

6.  The effect of hepatic lobectomy on some blood clotting factors and on fibrinolysis.

Authors:  M B ZUCKER; M SIEGEL; E E CLIFFTON; J W BELLVILLE; W S HOWLAND; C E GROSSI
Journal:  Ann Surg       Date:  1957-11       Impact factor: 12.969

7.  Anticoagulant action of protamine sulphate.

Authors:  C HOUGIE
Journal:  Proc Soc Exp Biol Med       Date:  1958-05

8.  INHIBITION BY PUROMYCIN OF AMINO ACID INCORPORATION INTO PROTEIN.

Authors:  M B Yarmolinsky; G L Haba
Journal:  Proc Natl Acad Sci U S A       Date:  1959-12       Impact factor: 11.205

9.  The labile factor of prothrombin conversion: its consumption under normal and pathological conditions affecting blood coagulation.

Authors:  B ALEXANDER; R GOLDSTEIN; G LANDWEHR
Journal:  J Clin Invest       Date:  1951-03       Impact factor: 14.808

10.  New one-stage procedures for the quantitative determination of prothrombin and labile factor.

Authors:  M STEFANINI
Journal:  Am J Clin Pathol       Date:  1950-03       Impact factor: 2.493
View more
  10 in total

1.  Identification of vitamin K-dependent carboxylase activity in lung type II cells but not in lung macrophages.

Authors:  R Wallin; S R Rannels
Journal:  Biochem J       Date:  1988-03-01       Impact factor: 3.857

2.  Immunohistochemical identification of factor X-like antigen in the A cells of the normal human pancreas.

Authors:  C Betterle; A Trevisan; A Girolami
Journal:  Diabetologia       Date:  1982-09       Impact factor: 10.122

Review 3.  Post-translational carboxylation of preprothrombin.

Authors:  B C Johnson
Journal:  Mol Cell Biochem       Date:  1981-08-11       Impact factor: 3.396

4.  Studies on hemorrhagic tendency in cirrhosis of the liver.

Authors:  R Yoshimura; H Asai; S Harihara; T Kamata; T Monna; S Yamamoto; T Fukuda; H Maeda
Journal:  Gastroenterol Jpn       Date:  1979-08

5.  Tissue factor activity in lymphocyte cultures from normal individuals and patients with hemophilia A.

Authors:  F R Rickles; J A Hardin; F A Pitlick; L W Hoyer; M E Conrad
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

6.  Mechanism of action of vitamin K: evidence for the conversion of a precursor protein to prothrombin in the rat.

Authors:  D V Shah; J W Suttie
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

7.  Biosynthesis of coagulation Factor V by a human hepatocellular carcinoma cell line.

Authors:  D B Wilson; H H Salem; J S Mruk; I Maruyama; P W Majerus
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

8.  Synthesis and turnover of prothrombin during experimental inflammation in rats.

Authors:  A Koj; E Regoeczi; P A Chindemi; J Gauldie
Journal:  Br J Exp Pathol       Date:  1984-12

9.  Production and control of coagulation proteins for factor X activation in human endothelial cells and fibroblasts.

Authors:  Clay T Cohen; Nancy A Turner; Joel L Moake
Journal:  Sci Rep       Date:  2020-02-06       Impact factor: 4.379

10.  Generation of coagulation factor V activity by cultured rabbit alveolar macrophages.

Authors:  H Rothberger; M P McGee
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.